Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2018 | Investigating the tumour microenvironment for immunotherapy in melanoma

Thomas Gajewski • 19 Oct 2018
ESMO 2018
Melanoma

Thomas Gajewski, MD, PhD, of the University of Chicago Comprehensive Cancer Center, Chicago, IL, speaks at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany. Prof. Gajewski discusses how his group is Investigating the tumour microenvironment to improve immunotherapy in melanoma.

More from Thomas Gajewski

1:45
Melanoma highlights from ESMO 2018
Thomas Gajewski • 19 Oct 2018
2:52
Promising immuno-oncology strategies for melanoma: LAG3, STING, RIG-I, TLR
Thomas Gajewski • 19 Oct 2018

Related Videos

1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
2:12
Novel immunotherapeutic approaches to treat patients with melanoma
Christoffer Gebhardt • 9 Apr 2024
1:22
INTerpath-001: individualized neoantigen vaccines with pembrolizumab in melanoma
Christoffer Gebhardt • 9 Apr 2024
2:15
Reducing the need for sentinel node biopsies in cutaneous melanoma
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals